NEC OncoImmunity AS

📍 Oslo, Norway🗓 Founded 2014👥 25 employees💰 Last funded Apr 2017
Biotechnology🌐 OncoImmunity.com
Website LinkedIn
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Norway
1
Frequently asked questions
Who invested in NEC OncoImmunity AS?
NEC OncoImmunity AS has 1 investors on record on gritt.io, 1 mid-stage.
When did NEC OncoImmunity AS last raise funding?
The most recent investment in NEC OncoImmunity AS recorded on gritt.io was in April 2017.
When was NEC OncoImmunity AS founded?
NEC OncoImmunity AS was founded in 2014.
What industry is NEC OncoImmunity AS in?
NEC OncoImmunity AS operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is NEC OncoImmunity AS based?
NEC OncoImmunity AS is headquartered in Oslo, Norway.